Literature DB >> 22405172

Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).

Randi Opheim1, Marte L Hoivik, Inger C Solberg, Bjorn Moum.   

Abstract

BACKGROUND AND AIMS: The use of complementary and alternative medicine (CAM) has been increasing in recent decades. Our aim was to determine the proportion of CAM use among patients with inflammatory bowel disease (IBD) in a longitudinal, population-based cohort and to identify predictive factors for CAM use.
METHODS: The Inflammatory Bowel South-Eastern Norway (IBSEN) study is a population-based IBD cohort that has been followed prospectively for 10 years. The ten-year follow-up was conducted from 2000 to 2004 and included a questionnaire regarding CAM, a structured interview, a review of hospital records, a clinical examination, laboratory tests, and an ileocolonoscopy.
RESULTS: Of the 620 patients evaluated at the ten-year follow-up, 517 (84%) completed the CAM questionnaire, 353 had ulcerative colitis (UC), 164 had Crohn's disease (CD), and 50% were male. Thirty percent reported the use of CAM at some point since their IBD diagnosis, and 7.5% reported current CAM use. More CD patients than UC patients reported CAM use (38% vs. 27%, respectively; p=0.01). Younger age, female gender, and higher education level predicted CAM use in UC, whereas younger age was the only predictor of CAM use in CD. Thirty-six percent of the CAM users were mostly satisfied or very satisfied with the treatment.
CONCLUSION: One third of the patients in this population-based cohort had used CAM at some point during a ten-year disease course, but only 7.5% reported current CAM use. CAM use was more common in the CD than in the UC patients. Only socio-demographic factors, such as age, gender and education, predicted CAM use. Copyright Â
© 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22405172     DOI: 10.1016/j.crohns.2011.09.007

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  14 in total

1.  Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.

Authors:  Réme Mountifield; Jane M Andrews; Antonina Mikocka-Walus; Peter Bampton
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Complementary Therapies in Inflammatory Bowel Diseases.

Authors:  Henit Yanai; Nir Salomon; Adi Lahat
Journal:  Curr Gastroenterol Rep       Date:  2016-12

Review 3.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

4.  Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.

Authors:  Francesca Borrelli; Barbara Romano; Stefania Petrosino; Ester Pagano; Raffaele Capasso; Diana Coppola; Giovanni Battista; Pierangelo Orlando; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

5.  Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Authors:  Soo Jung Park; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

6.  Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.

Authors:  Annelie Lindberg; Bjöörn Fossum; Per Karlen; Lena Oxelmark
Journal:  BMC Complement Altern Med       Date:  2014-10-22       Impact factor: 3.659

Review 7.  Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review.

Authors:  Maciej Sałaga; Hubert Zatorski; Marta Sobczak; Chunqiu Chen; Jakub Fichna
Journal:  Curr Treat Options Oncol       Date:  2014-09

8.  The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life.

Authors:  Randi Opheim; Marte Lie Høivik; Tomm Bernklev; Lars-Petter Jelsness-Jørgensen; Bjørn Moum
Journal:  Gastroenterol Res Pract       Date:  2016-11-27       Impact factor: 2.260

9.  Online Acceptance and Commitment Therapy and Nutrition Workshop for Parents of Children with Inflammatory Bowel Disease: Feasibility, Acceptability, and Initial Effectiveness.

Authors:  Sara Ahola Kohut; Inez Martincevic; Sheri L Turrell; Peter C Church; Thomas D Walters; Natalie Weiser; Armanda Iuliano
Journal:  Children (Basel)       Date:  2021-05-14

10.  Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis.

Authors:  Pauliina Nousiainen; Laura Merras-Salmio; Kristiina Aalto; Kaija-Leena Kolho
Journal:  BMC Complement Altern Med       Date:  2014-04-04       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.